Search Results

Investigators from Legacy Devers Eye Institute Report New Data on Open-Angle Glaucoma (A Phase 3 Adaptive Dose Selection Trial of Ncx 470, a Nitric Oxide-donating Bimatoprost for Open-angle Glaucoma or Ocular Hypertension: the Mont Blanc Study).

Subjects: OCULAR hypertension; OPEN-angle glaucoma; OPHTHALMIC drugsPORTLAND (Or.)

• Source: Clinical Trials Week; 12/9/2024, p361-361, 1p

Record details

Efficacy of Bimatoprost Plus Timolol Fixed Combination in Open Angle Glaucoma Patients Previously Treated with Dorzolamide Plus Timolol Fixed Combination.

• Authors : Sacchi, Matteo¹ (AUTHOR) ; Specchia, Claudia^2,3 (AUTHOR); Williams, Susan E.⁴ (AUTHOR)

Subjects: *BIMATOPROST; *TIMOLOL maleate; *OPEN-angle glaucoma

• Source: Current Eye Research. Nov2016, Vol. 41 Issue 11, p1433-1437. 5p.

Record details

Tear biomarkers in latanoprost and bimatoprost treated eyes.

• Authors : Reddy, Shweta¹; Sahay, Prity^1,2; Padhy, Debananda¹

Subjects: *TEARS (Body fluid); *BIMATOPROST; *CATARACT

• Source: PLoS ONE. 8/6/2018, Vol. 13 Issue 8, p1-13. 13p.

Record details

Researchers from State University of New York (SUNY) Upstate Medical University Detail Findings in Open-Angle Glaucoma (A Randomized, Controlled Comparison of Ncx 470, a Nitric Oxide-donating Bimatoprost, and Latanoprost In Subjects With...).

Subjects: OPEN-angle glaucoma; EYE diseases; OPHTHALMIC drugs

• Source: Clinical Trials Week; 8/6/2024, p966-966, 1p

Record details

Eyes on New Product Development.

• Authors : Novack, Gary D.^1,2 (AUTHOR)

Subjects: *NEW product development; *BIMATOPROST; *RANIBIZUMABUNITED StatesUNITED States. Food & Drug Administration

• Source: Journal of Ocular Pharmacology & Therapeutics. Apr2020, Vol. 36 Issue 3, p135-136. 2p.

Record details

Shaare Zedek Medical Center Researcher Highlights Recent Research in Macular Edema (Cystoid macular edema occurring after intracameral bimatoprost implantation).

Subjects: MACULAR edema; MEDICAL research personnel; BIMATOPROST

• Source: Health & Medicine Week; 5/3/2024, p5986-5986, 1p

Record details

An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects.

• Authors : Borchert, Mark; Bruce, Suzanne; Wirta, David

Subjects: BIMATOPROST; DRUG efficacy; EYELASHESUNITED States

• Source: Clinical Ophthalmology; Mar2016, Vol. 10, p419-429, 11p

Record details

Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial.

• Authors : Day, Douglas G.; Walters, Thomas R.; Schwartz, Gail F.

Subjects: BIMATOPROST; GLAUCOMA treatment; ANTIHYPERTENSIVE agents

• Source: British Journal of Ophthalmology; Aug2013, Vol. 97 Issue 8, p989-993, 5p

Record details

Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients.

• Authors : El Hajj Moussa, Wissam Georges; Farhat, Rebecca Georges; Nehme, Joseph Claud

Subjects: BIMATOPROST; PROSTAGLANDINS; GLAUCOMA

• Source: Journal of Ophthalmology; 3/7/2018, p1-7, 7p

Record details

Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension.

• Authors : Pfennigsdorf, Stefan; Ramez, Osman; von Kistowski, Gerrit

Subjects: BIMATOPROST; INTRAOCULAR pressure; BODY fluid pressure

• Source: Clinical Ophthalmology; 2012, Vol. 6, p739-746, 8p

Record details